Treatment of experimental chronic pulmonary mycoplasmosis

International Journal of Antimicrobial Agents

Volumn 28, Issue 3, 2006, Pages 253-258

  Fonseca Aten, Monica ^a   Rios, Ana Maria ^a   Mejias, Asuncion ^a   Chavez Bueno, Susana ^a   Katz, Kathy ^a   Gomez, Ana Maria ^a   Ramilo, Octavio ^a   McCracken, George H ^a   Hardy, R Doug ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Asthma; Chronic infection; Mycoplasma pneumoniae; Pneumonia; Reactive airway disease; Telithromycin

Indexed keywords

PLACEBO; TELITHROMYCIN;

AIRWAY OBSTRUCTION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PULMONARY MYCOPLASMOSIS; FEMALE; GRAM NEGATIVE INFECTION; LUNG FUNCTION; LUNG INFECTION; MOUSE; MYCOPLASMA PNEUMONIAE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; KETOLIDES; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA PNEUMONIAE; PLETHYSMOGRAPHY; PNEUMONIA, MYCOPLASMA;

EID: 33747145853     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.04.008     Document Type: Article

References (23)

1. Denny F.W., Clyde Jr. W.A., and Glezen W.P. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis 123 (1971) 74-92
2. Foy H.M., Grayston J.T., Kenny G.E., et al. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 197 (1966) 859-866
3. Smith C.B., Friedewald W.T., and Chanock R.M. Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med 276 (1967) 1172-1175
4. Hardy R.D., Jafri H.S., Olsen K., et al. Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease. Infect Immun 70 (2002) 649-654
5. Kraft M., Cassell G.H., Pak J., et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121 (2002) 1782-1788
6. Kim C.K., Chung C.Y., Kim J.S., et al. Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia. Pediatrics 105 (2000) 372-378
7. Martin R.J., Kraft M., Chu H.W., et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 107 (2001) 595-601
8. Hardy R.D., Jafri H.S., Olsen K., et al. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect Immun 69 (2001) 3869-3876
9. Hardy R.D., Rios A.M., Chavez-Bueno S., et al. Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. Antimicrob Agents Chemother 47 (2003) 1614-1620
10. Cimolai N., Taylor G.P., Mah D., et al. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol Immunol 36 (1992) 465-478
11. Gonzalo J.A., Lloyd C.M., Wen D., et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 188 (1998) 157-167
12. Schwarze J., Hamelmann E., Bradley K.L., et al. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 100 (1997) 226-233
13. Rubin B.K., and Henke M.O. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest 125 2 Suppl. (2004) 70S-78S
14. Hamelmann E., Schwarze J., Takeda K., et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156 (1997) 766-775
15. van Schaik S.M., Enhorning G., Vargas I., et al. Respiratory syncytial virus affects pulmonary function in BALB/c mice. J Infect Dis 177 (1998) 269-276
16. Tomkinson A., Cieslewicz G., Duez C., et al. Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice. Am J Respir Crit Care Med 163 (2001) 721-730
17. Adler A., Cieslewicz G., and Irvin C.G. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol 97 (2004) 286-292
18. Tessier P.R., Mattoes H.M., Dandekar P.K., et al. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model. Antimicrob Agents Chemother 49 (2005) 188-194
19. Zhanel G.G., Johanson C., Laing N., et al. Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary. Antimicrob Agents Chemother 49 (2005) 1943-1948
20. Rios A.M., Mejias A., Chavez-Bueno S., et al. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. Antimicrob Agents Chemother 48 (2004) 2897-2904
21. Fonseca-Aten M., Salvatore C.M., Mejías A., et al. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for the treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother 49 (2005) 4128-4136
22. Rios A.M., Fonseca-Aten M., Mejias A., et al. Microbiologic and immunologic evaluation of a single high dose of azithromycin for the treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother 49 (2005) 3970-3973
23. Dallo S.F., and Baseman J.B. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb Pathog 29 (2000) 301-309